Literature DB >> 6159320

Studies of two H-2Db mutants: B6. C-H-2bm13 and B6.C-H-2bm14.

G M Morgan, H Dellos, I F McKenzie, R W Melvold, D W Bailey.   

Abstract

Two new C57BL/6 H-2 mutants, B6.C-H-2bm13 and B6.C-H-2bm14 are described. They arose independently in C57BL/6 as spontaneous mutations of the gain and loss type. Complementation studies map the mutations in both bm13 and bm14 to the H-2Db gene. However, these two mutant strains are not identical, but occurred as independent mutations at the same locus, as shown by reciprocal graft rejection and by the inability of the (bm13 X bm14)F1 hybrid to accept C57BL/6 grafts. Serological studies by direct testing (cytotoxicity and hemagglutination) and by quantitative absorption demonstrated a decrease in the H-2Db private specificity H-2.2 in both bm13 and bm14 when compared to C57BL/6. This was confirmed by SDS-PAGE analysis using antisera detecting the H-2.2 specificity. Attempts to produce antibodies to either the gained or lost specificities of the two mutant strains failed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6159320     DOI: 10.1007/BF01567801

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  11 in total

1.  Histocompatibility gene mutation rates: H-2 and non-H-2.

Authors:  H I Melvold RW Kohn
Journal:  Mutat Res       Date:  1975-03       Impact factor: 2.433

2.  B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse.

Authors:  I F McKenzie; G M Morgan; M S Sandrin; M M Michaelides; R W Melvold; H I Kohn
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

3.  The firstH- 2 mutant workshop.

Authors:  H I Kohn; J Klein; R W Melvold; S G Nathenson; D Pious; D C Shreffler
Journal:  Immunogenetics       Date:  1978-12       Impact factor: 2.846

Review 4.  H-2 mutations: their genetics and effect on immune functions.

Authors:  J Klein
Journal:  Adv Immunol       Date:  1978       Impact factor: 3.543

5.  H-gene (histocompatibility) mutations induced by triethylenemelamine in the mouse.

Authors:  H I Kohn
Journal:  Mutat Res       Date:  1973-11       Impact factor: 2.433

6.  Mixed lymphocyte reaction caused by an H-2D mutation (congenic strains-B10.D2 new-B10.504).

Authors:  M Rychlíková; P Démant; I K Egorov
Journal:  Folia Biol (Praha)       Date:  1972       Impact factor: 0.906

7.  The definition of a new Ia antigenic specificity using the B6.C-H-2bml2 I-region mutant strain.

Authors:  G M Morgan; I F McKenzie; R W Melvold
Journal:  Immunogenetics       Date:  1980-07       Impact factor: 2.846

8.  Mutation in the IA subregion of the murine H-2 complex.

Authors:  I F McKenzie; M S Sandrin; G M Morgan; M M Henning; R W Melvold
Journal:  Immunogenetics       Date:  1980-07       Impact factor: 2.846

9.  A sensitive rosetting method for detecting subpopulations of lymphocytes which react with alloantisera.

Authors:  C R Parish; I F McKenzie
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

Review 10.  The use of H-2 mutants as models for the study of T cell activation.

Authors:  I F McKenzie; T Pang; R V Blanden
Journal:  Immunol Rev       Date:  1977       Impact factor: 12.988

View more
  9 in total

1.  Genetic control of the target structures recognized in hybrid resistance.

Authors:  J P Daley; J M Wroblewski; S G Kaminsky; I Nakamura
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

Review 2.  Genetics of beta-2 microglobulin in the mouse.

Authors:  J Michaelson
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

3.  Recognition of Db and Kb gene products by influenza-specific cytotoxic T cells.

Authors:  A R Townsend; P M Taylor; A L Mellor; B A Askonas
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

4.  Interaction of H-2Db with mutant histocompatibility gene H (KH-11) in the mouse.

Authors:  R W Melvold; H I Kohn; D W Bailey
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

5.  The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules.

Authors:  R Obst; N Netuschil; K Klopfer; S Stevanović; H G Rammensee
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

6.  Cytotoxic T lymphocyte nonresponsiveness to the male antigen H-Y in the H-2Db mutants bm13 and bm14. Complementation of the response in F1 crosses with the I-Ab mutant bm12 nonresponder and failure of B6 or Db mutant mice tolerant of each other to respond to allogeneic male cells.

Authors:  L P De Waal; R W Melvold; C J Melief
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

7.  Three spontaneous H-2Db mutants are generated by genetic micro-recombination (gene conversion) events. Impact on the H-2-restricted immune responsiveness.

Authors:  S Hemmi; J Geliebter; R A Zeff; R W Melvold; S G Nathenson
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

8.  Clonal deletion induced by either radioresistant thymic host cells or lymphohemopoietic donor cells at different stages of class I-restricted T cell ontogeny.

Authors:  D E Speiser; H Pircher; P S Ohashi; D Kyburz; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1992-05-01       Impact factor: 14.307

9.  Strictly transporter of antigen presentation (TAP)-dependent presentation of an immunodominant cytotoxic T lymphocyte epitope in the signal sequence of a virus protein.

Authors:  J Hombach; H Pircher; S Tonegawa; R M Zinkernagel
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.